Heterogeneous reactions are considered the heart of chemical synthesis with numerous
industrial applications due to their high conversion rates and low reaction time. On the other …

Continuous flow synthesis of active pharmaceutical ingredients (APIs) can offer access to
process conditions that are otherwise hazardous when operated in batch mode, resulting in …

Continuous flow synthesis in microreactors has been integrated into chemical-
pharmaceutical industry in recent years as an alternative to the batch process due to its …

The main drivers for application of small‐scale reactors in the pharmaceutical industry are
the possibility of rapid synthesis and screening of novel drugs as well as the readiness of the …

Microreactor Technology (MRT) appears as an interesting alternative for process
intensification, including the development of continuous synthesis of fine chemicals and …

Microreactor technology is increasingly applied in the chemical‐pharmaceutical industry for
safer and more efficient drug production as compared to the traditional batch process. This …

Microreactor technology is considered a breakthrough technology that can replace regular
reactors systems as microreactors deliver proper mixing and reaction performance which …

The use of flexible and cost‐effective manufacturing technologies for the production of active
pharmaceutical intermediates (APIs) is one major pathway toward solving drug shortage …

Síntese em fluxo em microrreatores é uma alternativa ao processo em batelada e vem
sendo incorporada à indústria químico-farmacêutica nos últimos anos devido às suas …

Objetivo: O presente trabalho teve como objetivo a realização de todas as etapas da síntese
do fármaco Pioglitazona em batelada e a transposição de uma das etapas para fluxo …